Publication Beamlines Strategic Pillar
Kaduk, James A.; Dosen, Anja; Blanton, Thomas N. (2025). Crystal structure of diroximel fumarate, C11H13NO6. Powder Diffraction , 1-6. 10.1017/s0885715625000119. BXDS-WLE Health
Kaduk, James A.; Dosen, Anja; Blanton, Thomas N. (2025). Crystal structure of etrasimod, C26H26F3NO3. Powder Diffraction , 1-6. 10.1017/s0885715625000107. BXDS-WLE Health
Kumar, Pawan; Zhang, Hongguang; Yohannes, Asfaw G.; Wang, Jiu; Shayesteh Zeraati, Ali et al. (2025). Isolated iridium oxide sites on modified carbon nitride for photoreforming of plastic derivatives. Nature Communications 16(1) . 10.1038/s41467-025-57999-w. BXDS, BXDS-WLE, HXMA, SGM Materials
Marangoni, Alejandro G.; Pensini, Erica (2025). Practical analysis of diffuse scattering patterns of inhomogeneous liquids. Physics of Fluids 37(3) . 10.1063/5.0256552. BXDS-WLE Materials
O'Connor, Ryan; Mofokeng, Thapelo P.; Haruna, Aderemi B.; Terban, Maxwell W.; Barrett, Dean H. et al. (2025). Excellent power and cycling stability of Mn2PO4F-based pseudocapacitor electrode: Ceria-induced electron-starvation of surface Mn2+ species. Journal of Power Sources 630, 236081. 10.1016/j.jpowsour.2024.236081. BXDS-WLE Materials
Panahi‐Sarmad, Mahyar; Ghaffarkhah, Ahmadreza; Bauman, Lukas Alexander; Babaei‐Ghazvini, Amin; Hashemi, Seyyed Alireza et al. (2025). Liquid Printing in Nanochitin Suspensions: Interfacial Nanoparticle Assembly Toward Volumetric Elements, Organic Electronics and Core–Shell Filaments. Small Methods . 10.1002/smtd.202500100. BMIT-BM, BXDS-WLE Materials
Pensini, Erica; Meszaros, Peter; Kashlan, Nour; Marangoni, Alejandro G.; Gregori, Stefano et al. (2025). Ferroelectric soft materials formed with alkanolamines and unsaturated fatty acids. Journal of Molecular Liquids 419, 126823. 10.1016/j.molliq.2024.126823. BXDS-WLE Materials
Shen, Poyen; Lavoie, Christian; Gall, Daniel (2025). Electron scattering at interfaces in Ru(0001)/Co(0001) multilayers. Journal of Applied Physics 137(2) . 10.1063/5.0241912. BXDS-WLE Materials
Teng, Youchao; Zhang, Zhilei; Cui, Yunqi; Su, Zhe; Godwin, Matthew et al. (2025). High‐Sensitivity and Flexible Motion Sensing Enabled by Robust, Self‐Healing Wood‐Based Anisotropic Hydrogel Composites. Small . 10.1002/smll.202500944. BXDS-WLE Materials
Yox, Philip; Teeter, Glenn; Baker, Lucas; Whitney, Drew; Maughan, Annalise E. et al. (2025). Directing Ion Transport and Interfacial Chemistry in Pnictogen-Substituted Thio-LISICONs. ACS Applied Materials and Interfaces . 10.1021/acsami.4c22390. BXDS-WHE, BXDS-WLE Materials
Colussi, Danielle M.; Grainger, Ryan; Noble, Megan; Lake, Taylor; Junop, Murray et al. (2025). Disrupting the network of co-evolving amino terminal domain residues relieves mitochondrial calcium uptake inhibition by MCUb. Computational and Structural Biotechnology Journal 27, 190-213. 10.1016/j.csbj.2024.12.007. [PDB: 8urg] CMCF-BM Health
Cottrell, Kevin M.; Briggs, Kimberly J.; Tsai, Alice; Tonini, Matthew R.; Whittington, Douglas A. et al. (2025). Discovery of TNG462: A Highly Potent and Selective MTA-Cooperative PRMT5 Inhibitor to Target Cancers with MTAP Deletion. Journal of Medicinal Chemistry 68(5) , 5097-5119. 10.1021/acs.jmedchem.4c03067. [PDB: 9n3o] CMCF-BM Health
Tran, Norman; Redzic, Jasmina S.; Eisenmesser, Elan Z.; Holyoak, Todd (2025). The structure of the Gemella haemolysans M26 IgA1 protease trypsin-like domain. Acta Crystallographica Section F:Structural Biology Communications 81(4) . 10.1107/s2053230x25001219. [PDB: 9ect] CMCF-BM Health
Cregg, James; Edwards, Anne V.; Chang, Stephanie; Lee, Bianca J.; Knox, John E. et al. (2025). Discovery of Daraxonrasib (RMC-6236), a Potent and Orally Bioavailable RAS(ON) Multi-selective, Noncovalent Tri-complex Inhibitor for the Treatment of Patients with Multiple RAS-Addicted Cancers. Journal of Medicinal Chemistry . 10.1021/acs.jmedchem.4c02314. [PDB: 9bg0, 9bg2, 9bg3, 9bg4, 9bg5, 9bg6, 9bg8, 9bga, 9bgb, 9bgc, 9bgd] CMCF-ID Health
Cregg, James; Pota, Kristof; Tomlinson, Aidan C. A.; Yano, Jason; Marquez, Abby et al. (2025). Discovery of Elironrasib (RMC-6291), a Potent and Orally Bioavailable, RAS(ON) G12C-Selective, Covalent Tricomplex Inhibitor for the Treatment of Patients with RAS G12C-Addicted Cancers. Journal of Medicinal Chemistry . 10.1021/acs.jmedchem.4c02313. [PDB: 9bfv, 9bfw] CMCF-ID Health